BioCentury | Nov 3, 2014
Finance

Shooting F-stars

...period. Fiscal 1H sales were up 3% to ¥851.4B ($7.7B). Sales of hypertension drug Azilva azilsartan...
BioCentury | Aug 4, 2014
Finance

Voucher leapfrog

...1Q sales were up less than 1% to ¥411.1B ($4.1B). Sales of hypertension drug Azilva azilsartan...
BioCentury | Jul 14, 2014
Company News

Takeda Pharmaceutical Co. Ltd sales and marketing update

...Takeda launched Zacras azilsartan/amlodipine besylate in Japan to treat hypertension. The once-daily, fixed-dose combination of azilsartan...
...both the 20 mg azilsartan/2.5 mg amlodipine and 20 mg azilsartan/5 mg amlodipine doses. Azilva azilsartan...
BioCentury | May 12, 2014
Finance

Zeroing in on immunity

...Japan fell 1% ¥582.1B ($5.7B) due to generic competition. However, sales of hypertension drug Azilva azilsartan...
BioCentury | Mar 31, 2014
Clinical News

Zacras azilsartan/amlodipine besylate regulatory update

...NDA for Zacras, a fixed-dose combination of azilsartan and amlodipine besylate, to treat hypertension. Azilva azilsartan...
...the U.S. and EU for hypertension. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Zacras azilsartan/amlodipine...
BioCentury | Dec 16, 2013
Strategy

Out in the cold

...testosterone gel Endo Express Scripts ARBs and ARB/diuretic combos (A) Edarbi azilsartan Arbor/Takeda Both Edarbyclor azilsartan...
BioCentury | Sep 23, 2013
Company News

Arbor Pharmaceuticals, Takeda sales and marketing update

...Pharmaceuticals Ireland Ltd. subsidiary exclusive rights to commercialize hypertension drugs Edarbi azilsartan medoxomil and Edarbyclor azilsartan...
...angiotensin II type 1 (AT1) receptor blocker (ARB), and Edarbyclor is a fixed-dose combination of azilsartan...
BioCentury | Apr 29, 2013
Clinical News

Azilva azilsartan/amlodipine besylate regulatory update

...Welfare (MHLW) for a fixed-dose combination of Azilva azilsartan and amlodipine besylate to treat hypertension. Azilva...
...the U.S. and EU for hypertension. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Azilva azilsartan/amlodipine...
BioCentury | Oct 8, 2012
Clinical News

Azilsartan medoxomil regulatory update

...that within the first 8 months of this year, it submitted a regulatory application for azilsartan...
...EU, where it is marketed as Edarbi. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Azilsartan...
BioCentury | Oct 8, 2012
Clinical News

Edarbyclor azilsartan medoxomil/chlorthalidone regulatory update

...said that within the first 8 months of this year, it submitted regulatory applications for azilsartan...
...medoxomil/chlorthalidone in Taiwan, Thailand and Indonesia to treat hypertension. Takeda markets the fixed-dose combination of azilsartan...
...AT1) receptor blocker, and chlorthalidone, a long-acting oral thiazide-like diuretic, as Edarbyclor in the U.S. Azilsartan...
Items per page:
1 - 10 of 42